Earth Science Tech
OTC: ETST
$0.14 ▲ +0.00  (+0.00%)
At close: Jul 21, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap34.44 Mn
P/E9.56
P/S0.96
Div. Yield0.00
ROIC (Qtr)0.21
Revenue Growth (1y) (Qtr)9.46
Add ratio to table…

About

Earth Science Tech, Inc. operates as a strategic holding company focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The company leverages a diversified portfolio of subsidiaries to create synergies across pharmacy, telemedicine, real estate, healthcare services, and consumer products. Earth Science Tech, Inc. generates revenue primarily from product sales of compounded medications through its RxCompound…

Read more ↓
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic CIK: 0001538495

Product and Service Breakdown of Revenue (2026)

Peer Comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HLN Haleon plc 88.07 Bn103.296.0011.45 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 35.75 Bn23.022.0616.63 Bn
3 ZTS Zoetis Inc. 31.84 Bn12.053.359.05 Bn
4 TAK Takeda Pharmaceutical Co Ltd 27.18 Bn-10.290.5928.76 Bn
5 UTHR UNITED THERAPEUTICS Corp 23.09 Bn17.937.28-
6 RDHL RedHill Biopharma Ltd. 21.32 Bn2,931.662.24-
7 VTRS Viatris Inc 19.96 Bn-67.321.3714.34 Bn
8 NBIX Neurocrine Biosciences Inc 17.66 Bn26.415.69-